AHX — Apiam Animal Health Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedMicro CapContrarian
- AU$82.93m
- AU$177.81m
- AU$191.76m
- 77
- 88
- 23
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 4.69 | ||
| PEG Ratio (f) | 0.1 | ||
| EPS Growth (f) | 88.32% | ||
| Dividend Yield (f) | 6.42% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.7 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 9.01 | ||
| Price to Sales | 0.43 | ||
| EV to EBITDA | 10.59 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.09% | ||
| Return on Equity | 2.01% | ||
| Operating Margin | 3.43% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 111.72 | 118.33 | 126.18 | 157.06 | 191.76 | 206.1 | 218.6 | 12.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -15.11 | +20.04 | +8.41 | +1.21 | -67.73 | +335.09 | +11.48 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Apiam Animal Health Limited is an Australia-based animal health company. The Company is engaged in the provision of veterinary products and services for production and companion animals across three segments: dairy and mixed, feedlot, and pigs. Its service areas include veterinary services, research, education, records, product supply and diagnostics. Its species and ancillary services include dairy services, swine and poultry services, beef feedlot services, equine services, sheep services, genetic services, and others. The flagship ProDairy Program developed by the Company is purposely designed for dairy farmers. Under the Fur Life Vet banner, its clinics are dedicated to small animals and its mixed practice clinics provide services for domestic pets and their owners, including the Best Mates Program. It operates a vertically integrated business with logistics, wholesale procurement arm, laboratory services and manufactures autogenous vaccines and private label products.
Directors
- Andrew Vizard NEC
- Matthew White CFO
- Brian Scutt COO
- Christopher Richards MDR
- Eryl Baron SEC
- Michael Blommestein NID
- Richard Dennis NID
- Jan Tennent NID
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- March 25th, 2015
- Public Since
- December 15th, 2015
- No. of Shareholders
- 1,830
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 276,435,197
- Address
- East Bendigo, 27-33 Piper Lane, BENDIGO, 3550
- Web
- https://www.apiam.com.au/
- Phone
- +61 354455999
- Auditors
- Grant Thornton Audit Pty Ltd
Upcoming Events for AHX
Similar to AHX
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Capitol Health
Australian Stock Exchange - SEATS
Careteq
Australian Stock Exchange - SEATS
FAQ
What is the Apiam Animal Health share price?
As of Today at 12:02 UTC, shares in Apiam Animal Health are trading at AU$0.30. This share price information is delayed by 15 minutes.
How has the Apiam Animal Health share price performed this year?
Shares in Apiam Animal Health last closed at AU$0.30 and the price had moved by -57.14% over the past 365 days. In terms of relative price strength the Apiam Animal Health share price has underperformed the ASX All Ordinaries Index by -55.64% over the past year.
What are the analyst and broker recommendations for Apiam Animal Health?
The overall consensus recommendation for Apiam Animal Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Apiam Animal Health dividend yield?
Apiam Animal Health does not currently pay a dividend.
Does Apiam Animal Health pay a dividend?
Apiam Animal Health does not currently pay a dividend.
When does Apiam Animal Health next pay dividends?
Apiam Animal Health does not currently pay a dividend.
How do I buy Apiam Animal Health shares?
To buy shares in Apiam Animal Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Apiam Animal Health?
As of the previous close price of AU$0.30, shares in Apiam Animal Health had a market capitalisation of AU$82.93m.
Where are Apiam Animal Health shares listed?
Here are the trading details for Apiam Animal Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AHX
What kind of share is Apiam Animal Health?
Based on an overall assessment of its quality, value and momentum Apiam Animal Health is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Apiam Animal Health share price forecast for 2023?
The analyst consensus target price for shares in Apiam Animal Health is AU$3.20. That is 966.67% above the last closing price of AU$0.30.
Analysts covering Apiam Animal Health currently have a consensus Earnings Per Share (EPS) forecast of AU$0.06 for the next financial year.
What is the trend in the Apiam Animal Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apiam Animal Health. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -40.34%.
As of the last closing price of AU$0.30, shares in Apiam Animal Health were trading -34.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Apiam Animal Health PE Ratio?
The Apiam Animal Health PE ratio based on its reported earnings over the past 12 months is 4.69. The shares last closed at AU$0.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Apiam Animal Health?
Apiam Animal Health's management team is headed by:
- Andrew Vizard - NEC
- Matthew White - CFO
- Brian Scutt - COO
- Christopher Richards - MDR
- Eryl Baron - SEC
- Michael Blommestein - NID
- Richard Dennis - NID
- Jan Tennent - NID